| # | Drug | Count |
|---|---|---|
| 0 | CITALOPRAM | 37 |
| 1 | CITALOPRAM HYDROBROMIDE | 37 |
| 2 | IBUPROFEN | 37 |
| 3 | MORPHINE | 36 |
| 4 | PREDNISOLONE | 36 |
| 5 | PREDNISOLONE ORAL | 36 |
| 6 | PREDNISOLONE ORAL SOLUTION | 36 |
| 7 | VALSARTAN | 36 |
| 8 | BACLOFEN | 35 |
| 9 | CYCLOPHOSPHAMIDE | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ENALAPRILAT | 3 | 0.0118 |
| 1 | CLORAZEPATE DIPOTASSIUM | 21 | 0.0107 |
| 2 | DACARBAZINE | 35 | 0.0046 |
| 3 | BLEOMYCIN SULFATE | 34 | 0.0033 |
| 4 | TOLCAPONE | 1 | 0.0028 |
| 5 | PEGFILGRASTIM | 34 | 0.0028 |
| 6 | SEVOFLURANE | 13 | 0.0015 |
| 7 | FLUTAMIDE | 1 | 0.0010 |
| 8 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 9 | CLONIDINE | 30 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Opioid Agonist [EPC] | 50 |
| 1 | Corticosteroid [EPC] | 45 |
| 2 | Benzodiazepine [EPC] | 42 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 41 |
| 4 | Alkylating Drug [EPC] | 38 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 36 |
| 6 | Serotonin Reuptake Inhibitor [EPC] | 36 |
| 7 | Topoisomerase Inhibitor [EPC] | 35 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 35 |
| 9 | Leukocyte Growth Factor [EPC] | 34 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Central alpha-2 Adrenergic Agonist [EPC] | 30 | 0.0006 |
| 1 | Topoisomerase Inhibitor [EPC] | 35 | 0.0005 |
| 2 | Serotonin Reuptake Inhibitor [EPC] | 36 | 0.0004 |
| 3 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 35 | 0.0004 |
| 4 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | General Anesthetic [EPC] | 13 | 0.0003 |
| 6 | Leukocyte Growth Factor [EPC] | 34 | 0.0002 |
| 7 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Opioid Agonist [EPC] | 50 | 0.0002 |
| 9 | Bile Acid Sequestrant [EPC] | 2 | 0.0002 |